North Eastern German Society Of Gynaecological Oncology

This study follows over 1,100 women with early-stage, hormone-sensitive breast cancer to see if those with a low-risk result on the EndoPredict® gene test can safely avoid chemotherapy and use only hormone therapy. Researchers are tracking whether these patients remain cancer-fre…